名称:Roche Pharma(Schweiz) Ltd 地址:Schoenmattstrasse 2 CH-4153 Reinach Switzerland 电话: 邮箱: 传真: 官网:http://www.roche.com.cn/portal/eipf/china/cn/NCT-CN 邮编:0 联系人: 药企热搜榜 1荣昌制药(淄博)有限公司5205 电话:0533-6200879 ...
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
6) Societe anonyme du chrome of Switzerland 瑞士铬业有限公司补充资料:复华证券金融公司股份有限公司 复华证券金融公司股份有限公司 【复华证券金融公司股份有限公司】依据台湾“证券交易法”和“银行法”有关规定经“财政部”许可及“财政部证券管理委员会”核准成立的经营资本市场业务的股份有限公司。公营金融机构...
Rotkreuz is located in the heart of Switzerland in Canton Zug, halfway between Lucerne and Zurich and only 30 minutes from Zurich airport. Zug is situated in the centre of a medtech cluster consisting of numerous other medicinal technology, pharma and healthcare companies and universities and oth...
To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. In recognizing our endeavour to pursue a long-term perspective in all w...
Actemra is also approved for the treatment of Castleman’s Disease, adult Still's disease and Takayasu Arteritis. Actemra/RoActemra is part of a co-development agreement with Chugai Pharmaceutical Co., Ltd and has been approved in Japan sin...
BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. As an important member of the Roche Group, Chugai is actively...
Commenting on this new collaboration James Sabry, head of Roche Pharma Partnering said, “We are excited to enter this licensing agreement with Sarepta. By working together to provide SRP-9001 to patients, we hope to fundament...
pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders an...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) has approved Xofluza™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years of age and older. Xofluza is a first-in-class, si...